NorthWest Biotherapeutics Inc (NWBO): Agree the price can be higher. If we fol...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

NorthWest Biotherapeutics Inc (NWBO)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	77
Posts	2228
Boards Moderated	0
Alias Born	01/31/2014

Re: biosectinvestor post# 431092

Friday, 12/31/2021 7:40:32 PM

Friday, December 31, 2021 7:40:32 PM

Agree the price can be higher. If we follow a higher-efficacy-drug gets to charge a higher price model (like UK) I would be happy with that too.

On the other hand, I would like Northwest to be the responsible adult in the house, not too greedy.

Most cancer treatments are prohibitively expensive. As for the expected cost of DCVAX-L, judging from talking with people who have previously undergone treatment in the UK, I believe t it is possible that DCVAX-L might be priced at half the cost of the approved immune therapies offered by Big Pharma.

https://www.heraldtribune.com/story/business/2021/12/30/joan-lappin-biotech-firm-nwbo-gets-uk-approval-special-treatment/9025652002/

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NWBO News

Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM

More NWBO News

InvestorsHub NewsWire

LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM

DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM

BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM

Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM

ConnectM Subsidiary Signs Definitive Agreement with Alpex Solar to Execute Solar Deployments Worth an Initial ~$16.5M • CNTM • Feb 4, 2026 9:05 AM

The Hidden Revenue Drain in Hospitality-and How AI Robotics Is Finally Closing the Gap • NGTF • Feb 4, 2026 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow